162
Participants
Start Date
April 27, 2015
Primary Completion Date
March 14, 2016
Study Completion Date
March 14, 2016
Benralizumab
Benralizumab administered subcutaneously every 4 weeks
Research Site, Fountain Valley
Research Site, Walnut Creek
Research Site, Celebration
Research Site, Ocala
Research Site, Orlando
Research Site, Winter Park
Research Site, Albany
Research Site, Minneapolis
Research Site, St Louis
Research Site, Bellevue
Research Site, Oklahoma City
Research Site, San Antonio
Research Site, Calgary
Research Site, Vancouver
Research Site, Ajax
Research Site, Burlington
Research Site, Mississauga
Research Site, Toronto
Research Site, Montreal
Research Site, Pointe-Claire
Research Site, Québec
Research Site, Saint-Charles-Borromée
Research Site, Trois-Rivières
Lead Sponsor
AstraZeneca
INDUSTRY